New vaccine trial aims to boost immune defense against Cancer-Causing virus in people with HIV
NCT ID NCT07090174
Summary
This study is testing an experimental vaccine called PDS0101 in adults living with HIV who also have an HPV 16 infection. The goal is to see if the vaccine is safe and can help the immune system fight the HPV virus, which can cause cervical and anal cancers. All 27 participants will receive three doses of the vaccine, and researchers will monitor for side effects and measure immune responses over several months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Medical Center/Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Puerto Rico
San Juan, 00935, Puerto Rico
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Weill Cornell Medical College
New York, New York, 10010, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.